The 2004 BMW M3 CSL arrived at a moment when performance cars were getting heavier, more complex and more insulated, yet it ...

Here's what to expect from the Australian-based global biotechnology company this year. The post Prediction: CSL shares could ...

CSL Ltd (ASX: CSL) shares slumped in 2025, but the outlook may be improving. Here’s why I think CSL could beat the ASX 200 ...

BMW has brought back the 3.0 CSL name on a new limited-edition sports car that echoes the design of the original '70s-era 3.0 CSL and sports a motorsports-inspired livery. The twin-turbo 3.0-liter ...

CSL Ltd (ASX: CSL) shares were sold off in 2025. Let's find out why and see if this is a buying opportunity for ...

Steven Ewing spent his childhood reading car magazines, making his career as an automotive journalist an absolute dream job. After getting his foot in the door at Automobile while he was still a ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. The company had been ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine subsidiary in a wide-ranging restructure. The Melbourne-headquartered company will ...